Status:
TERMINATED
The Effect of MK0633 in Patients With Chronic Asthma (0633-007)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Asthma
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
A clinical study to evaluate the efficacy and safety of MK0633 in adult patients with chronic asthma.
Eligibility Criteria
Inclusion
- Documented clinical history of symptoms of chronic asthma, including dyspnea, wheezing, chest tightness, cough, and/or sputum production
- Males and females 18-70 years of age
Exclusion
- History of kidney or chronic liver disease
- Recent history of heart problems within the past 3 months
- Evidence of another clinically significant, active lung disorder such as bronchiectasis or COPD
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
688 Patients enrolled
Trial Details
Trial ID
NCT00404313
Start Date
January 1 2008
End Date
June 1 2009
Last Update
October 20 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.